Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request, 22502-22504 [2014-09186]
Download as PDF
<![CDATA[
22502
Federal Register / Vol. 79, No. 77 / Tuesday, April 22, 2014 / Notices
TABLE 1—REQUESTS TO WITHDRAW APPROVAL OF APPLICATIONS—Continued
Application No.
Drug
Applicant
ANDA 076315 ....
Topiramate Tablets, 25 mg, 100 mg, and 200 mg ..................
ANDA 076372 ....
ANDA 076398 ....
Brimonidine Tartrate Ophthalmic Solution, 0.2% .....................
Tamoxifen Citrate Tablets USP, 10 mg and 20 mg ................
ANDA 076424 ....
Fluconazole Tablets, 50 mg, 100 mg, 150 mg, and 200 mg ..
ANDA 076448 ....
ANDA 076529 ....
Topiramate Capsules, 15 mg and 25 mg ................................
Loratadine Syrup (loratadine oral solution USP), 1 mg/mL .....
ANDA 076540 ....
ANDA 076612 ....
Sertraline HCl Tablets, 25 mg, 50 mg, and 100 mg ...............
Benazepril HCl and Hydrochlorothiazide Tablets, 5 mg/6.25
mg, 10 mg/12.5 mg, 20 mg/12.5 mg, and 20 mg/25 mg.
Metoprolol Succinate Extended-Release Tablets, 100 mg and
200 mg.
Fluticasone Proprionate Cream, 0.05% ...................................
Prednisolone Sodium Phosphate Oral Solution USP, 5 mg/5
mL.
Ciprofloxacin Injection USP, 10 mg/mL ...................................
Ciprofloxacin Injection USP, 10 mg/mL ...................................
Lorazepam Injection USP (Preservative-Free), 2 mg/mL and
4 mg/mL.
Lorazepam Injection USP, 2 mg/mL and 4 mg/mL, 10 mL per
vial.
Amlodipine Besylate Tablets, 2.5 mg, 5 mg, and 10 mg ........
Barr Laboratories, Inc., an indirect, wholly owned subsidiary
of Teva Pharmaceuticals USA, 400 Chestnut Ridge Rd.,
Woodcliff Lake, NJ 07677.
Teva Parenteral Medicines, Inc.
Aegis Pharmaceuticals PLC, c/o GlobePharm Inc., 313 Pine
St., Suite 204, Deerfield, IL 60015.
Pliva Inc., c/o Barr Laboratories Inc., an indirect, wholly
owned subsidiary of Teva Pharmaceuticals USA, U.S.
Agent, 400 Chestnut Ridge Rd., Woodcliff Lake, NJ 07677.
Barr Laboratories, Inc.
Ranbaxy Laboratories Limited, c/o Ranbaxy Inc., U.S., 600
College Rd. East, Princeton, NJ 08540.
Mylan Pharmaceuticals, Inc.
Do.
ANDA 076640 ....
ANDA 076865 ....
ANDA 076982 ....
ANDA 076992 ....
ANDA 076993 ....
ANDA 077074 ....
ANDA 077076 ....
ANDA 077080 ....
ANDA
ANDA
ANDA
ANDA
077085
077311
085917
087423
....
....
....
....
tkelley on DSK3SPTVN1PROD with NOTICES
ANDA 087433 ....
Leflunomide Tablets, 10 mg and 20 mg ..................................
Hydromorphone HCl Tablets USP, 2 mg, 4 mg, and 8 mg ....
Acetaminophen and Codeine Phosphate Tablets, 30 mg .......
Acetaminophen and Codeine Phosphate Tablets, 300 mg/60
mg.
Acetaminophen and Codeine Phosphate Tablets, 300 mg/15
mg.
Therefore, under section 505(e) of the
Federal Food, Drug, and Cosmetic Act
(the FD&C Act) (21 U.S.C. 355(e)) and
under authority delegated to the
Director, Center for Drug Evaluation and
Research, by the Commissioner,
approval of the applications listed in
table 1 in this document, and all
amendments and supplements thereto,
is hereby withdrawn, effective May 22,
2014. Introduction or delivery for
introduction into interstate commerce of
products without approved new drug
applications violates section 301(a) and
(d) of the FD&C Act (21 U.S.C. 331(a)
and (d)). Drug products that are listed in
table 1 that are in inventory on the date
that this notice becomes effective (see
the DATES section) may continue to be
dispensed until the inventories have
been depleted or the drug products have
reached their expiration dates or
otherwise become violative, whichever
occurs first.
Nesher Pharmaceuticals (USA) LLC.
Do.
Do.
Bedford Laboratories.
Do.
Do.
Do.
Synthon Pharmaceuticals, Inc., 9000 Development Dr., P.O.
Box 110487, Research Triangle Park, NC 27709.
Sandoz Inc.
Nesher Pharmaceuticals (USA) LLC.
Sandoz Inc.
Do.
Do.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
AGENCY:
ACTION:
Notice.
Dated: April 17, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
[FR Doc. 2014–09124 Filed 4–21–14; 8:45 am]
DATES:
BILLING CODE 4160–01–P
VerDate Mar<15>2010
16:26 Apr 21, 2014
Jkt 232001
SUMMARY:
Comments on this ICR should be
received no later than May 22, 2014.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to OIRA_
submission@omb.eop.gov or by fax to
202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Children’s Hospitals Graduate Medical
Education Payment Program.
OMB No.: 0915–0247 Revision.
Abstract: The Children’s Hospitals
Graduate Medical Education (CHGME)
Payment Program was enacted by Public
Law 106–129 to provide federal support
for graduate medical education (GME) to
freestanding children’s hospitals. This
legislation attempts to provide support
for GME comparable to the level of
Medicare GME support received by
other, non-children’s hospitals. The
legislation requires that eligible
children’s hospitals receive payments
for both direct and indirect medical
ADDRESSES:
E:\FR\FM\22APN1.SGM
22APN1
22503
Federal Register / Vol. 79, No. 77 / Tuesday, April 22, 2014 / Notices
education expenses. Payments for direct
expenses offset the expenses associated
with operating approved graduate
medical residency training programs,
and payments for indirect expenses
compensate hospitals for expenses
associated with the treatment of more
severely ill patients and the additional
costs relating to teaching residents in
such programs. The Centers for
Medicare and Medicaid Services (CMS)
issued a final rule in the Federal
Register regarding Sections 5503, 5504,
5505, and 5506 of the Affordable Care
Act of 2010, Public Law 111–148, on
Wednesday, November 24, 2010. This
final rule included policy changes on
counting resident time in non-provider
settings, counting resident time for
didactic training and the redistribution
of resident caps, which required
modification of the data collection
forms within the CHGME Payment
Program application. The necessary
modifications were made and received
OMB clearance on June 30, 2012.
On September 30, 2013, CMS
published revised cost report forms on
their Web site; specifically form CMS
2552–10, Worksheet E–4, requiring
additional modifications of the data
collection forms in the CHGME Payment
Program application. The CHGME
Payment Program application forms
have been adjusted to accommodate the
most recent CMS policy changes. These
changes require OMB approval.
Need and Proposed Use of the
Information: Data are collected on the
number of full-time equivalent (FTE)
residents in applicant children’s
hospitals’ training programs to
determine the amount of direct and
indirect medical education payments to
be distributed to participating children’s
hospitals. Indirect medical education
payments will also be derived from a
formula that requires the reporting of
discharges, beds, and case mix index
information from participating
children’s hospitals.
Hospitals will also be requested to
submit data on the number of FTE
residents trained during the federal
fiscal year to participate in the
reconciliation payment process.
Auditors will be requested to submit
data on the number of full-time
equivalent residents trained by the
hospitals in an FTE resident assessment
summary. An assessment of the hospital
data ensures that appropriate CMS
regulations and CHGME program
guidelines are followed in determining
which residents are eligible to be
claimed for funding. The audit results
impact final payments made by the
CHGME Payment Program to all eligible
hospitals.
Likely Respondents: Hospitals
applying for and receiving CHGME
funds and fiscal intermediaries auditing
data submitted by the hospitals
receiving CHGME funds.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
tkelley on DSK3SPTVN1PROD with NOTICES
Form name
Application Cover Letter (Initial) ..........................................
Application Cover Letter (Reconciliation) ............................
HRSA 99 (Initial) ..................................................................
HRSA 99 (Reconciliation) ....................................................
HRSA 99–1 (Initial) ..............................................................
HRSA 99–1 (Reconciliation) ................................................
HRSA 99–1 (Supplemental) (FTE Resident Assessment) ..
HRSA 99–2 (Initial) ..............................................................
HRSA 99–2 (Reconciliation) ................................................
HRSA 99–4 (Reconciliation) ................................................
HRSA 99–5 (Initial) ..............................................................
HRSA 99–5 (Reconciliation) ................................................
CFO Form Letter (Initial) ......................................................
CFO Form Letter (Reconciliation) ........................................
FTE Resident Assessment Cover Letter (FTE Resident
Assessment) .....................................................................
Conversation Record (FTE Resident Assessment) .............
Exhibit C (FTE Resident Assessment) ................................
Exhibit F (FTE Resident Assessment) ................................
Exhibit N (FTE Resident Assessment) ................................
Exhibit O(1) (FTE Resident Assessment) ...........................
Exhibit O(2) (FTE Resident Assessment) ...........................
Exhibit P (FTE Resident Assessment) ................................
Exhibit P(2) (FTE Resident Assessment) ............................
Exhibit S (FTE Resident Assessment) ................................
Exhibit T (FTE Resident Assessment) ................................
Exhibit T(1) (FTE Resident Assessment) ............................
Exhibit 1 (FTE Resident Assessment) .................................
Exhibit 2 (Initial, Reconciliation and FTE Resident Assessment) ................................................................................
Exhibit 3 (Initial, Reconciliation and FTE Resident Assessment) ................................................................................
VerDate Mar<15>2010
16:26 Apr 21, 2014
Jkt 232001
PO 00000
Frm 00035
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
60
60
60
60
60
60
30
60
60
60
60
60
60
60
60
60
60
60
60
60
30
60
60
60
60
60
60
60
0.33
0.33
0.33
0.33
26.50
6.50
3.67
11.33
3.67
12.50
0.33
0.33
0.33
0.33
19.8
19.8
19.8
19.8
1,590.0
390.0
110.1
679.8
220.2
750.0
19.8
19.8
19.8
19.8
30
30
30
30
30
30
30
30
30
30
30
30
30
1
1
1
1
1
1
1
1
1
1
1
1
1
30
30
30
30
30
30
30
30
30
30
30
30
30
0.33
3.67
3.67
3.67
3.67
3.67
26.50
3.67
3.67
3.67
3.67
3.67
0.33
9.9
110.1
110.1
110.1
110.1
110.1
795.0
110.1
110.1
110.1
110.1
110.1
9.9
90
1
90
0.33
29.7
90
Fmt 4703
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
90
0.33
29.7
Sfmt 4703
E:\FR\FM\22APN1.SGM
22APN1
22504
Federal Register / Vol. 79, No. 77 / Tuesday, April 22, 2014 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Exhibit 4 (Initial, Reconciliation and FTE Resident Assessment) ................................................................................
90
1
90
0.33
29.7
Total ..............................................................................
90
........................
90
........................
5,962.8
Dated: April 14, 2014.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2014–09186 Filed 4–21–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission to OMB for
Review and Approval; Public Comment
Request
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health
Resources and Services Administration
(HRSA) has submitted an Information
Collection Request (ICR) to the Office of
Management and Budget (OMB) for
review and approval. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public during the review and
approval period.
DATES: Comments on this ICR should be
received no later than May 22, 2014.
ADDRESSES: Submit your comments,
including the Information Collection
Request Title, to the desk officer for
HRSA, either by email to OIRA_
submission@omb.eop.gov or by fax to
202–395–5806.
FOR FURTHER INFORMATION CONTACT: To
request a copy of the clearance requests
submitted to OMB for review, email the
HRSA Information Collection Clearance
Officer at paperwork@hrsa.gov or call
(301) 443–1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title:
Healthy Start Evaluation and Quality
Assurance OMB No. 0915–0338—
Revision
Abstract: The National Healthy Start
Program, funded through the Health
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:26 Apr 21, 2014
Jkt 232001
Resources and Services
Administration’s (HRSA’s) Maternal and
Child Health Bureau (MCHB), has the
goal of reducing disparities in infant
mortality and adverse perinatal
outcomes. The program began as a
demonstration project with 15 grantees
in 1991 and has expanded over the past
2 decades to 105 grantees serving 196
communities across 39 states. Healthy
Start grantees operate in communities
with rates of infant mortality at least 1.5
times the U.S. national average and high
rates for other adverse perinatal
outcomes. These communities are
geographically, racially, ethnically, and
linguistically diverse low-income areas.
Healthy Start covers services during the
perinatal period (before, during, after
pregnancy) and follows the woman and
infant through 2 years after the end of
the pregnancy. The next round of
funding represents a transformation of
the program framework from nine
service and systems core components to
five approaches. The five approaches
are as follows: (1) Improving women’s
health; (2) promoting quality services;
(3) strengthening family resilience; (4)
achieving collective impact; and (5)
increasing accountability through
quality assurance, performance
monitoring, and evaluation.
MCHB seeks to implement a uniform
set of data elements for monitoring and
conduct a mixed-methods evaluation to
assess the effectiveness of the program
on individual, organizational, and
community-level outcomes. Data
collection instruments will include a
Preconception, Pregnancy, and
Parenting Information Form; National
Healthy Start Program Survey;
Community Action Network Survey;
Healthy Start Site Visit Protocol; and
Healthy Start Participant Focus Group
Protocol.
Need and Proposed Use of the
Information: The purpose of the data
collection instruments will be to obtain
consistent information across all
grantees about Healthy Start and its
outcomes for purposes of monitoring,
and in-depth information for 15 Healthy
Start communities and 15 comparison
communities to support a rigorous
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
evaluation design. The data will be used
to: (1) Conduct ongoing performance
monitoring of the program; (2) provide
credible and rigorous evidence of
program effect on outcomes; (3) assess
the relative contribution of the five
program approaches to individual and
community-level outcomes; (4) meet
program needs for accountability,
programmatic decision-making, and
ongoing quality assurance; and (5)
strengthen the evidence-base, and
identify best and promising practices for
the program to support sustainability,
replication, and dissemination of the
program.
Likely Respondents: Respondents
include pregnant women and women of
reproductive age who are served by the
Healthy Start program (monitoring) and
sampled postpartum women from 15
unfunded organizations in comparison
communities (evaluation) for the
Preconception, Pregnancy, and
Parenting Information Form; project
directors and staff for the National
Healthy Start Program Survey;
representatives from partner
organizations for the Community Action
Network Survey; program staff,
providers, and partners for the Healthy
Start Site Visit Protocol; and program
participants for the Healthy Start
Participant Focus Group Protocol.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 79, Number 77 (Tuesday, April 22, 2014)]
[Notices]
[Pages 22502-22504]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09186]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission to OMB for
Review and Approval; Public Comment Request
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Health Resources and Services Administration
(HRSA) has submitted an Information Collection Request (ICR) to the
Office of Management and Budget (OMB) for review and approval. Comments
submitted during the first public review of this ICR will be provided
to OMB. OMB will accept further comments from the public during the
review and approval period.
DATES: Comments on this ICR should be received no later than May 22,
2014.
ADDRESSES: Submit your comments, including the Information Collection
Request Title, to the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by fax to 202-395-5806.
FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance
requests submitted to OMB for review, email the HRSA Information
Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443-
1984.
SUPPLEMENTARY INFORMATION:
Information Collection Request Title: Children's Hospitals Graduate
Medical Education Payment Program.
OMB No.: 0915-0247 Revision.
Abstract: The Children's Hospitals Graduate Medical Education
(CHGME) Payment Program was enacted by Public Law 106-129 to provide
federal support for graduate medical education (GME) to freestanding
children's hospitals. This legislation attempts to provide support for
GME comparable to the level of Medicare GME support received by other,
non-children's hospitals. The legislation requires that eligible
children's hospitals receive payments for both direct and indirect
medical
[[Page 22503]]
education expenses. Payments for direct expenses offset the expenses
associated with operating approved graduate medical residency training
programs, and payments for indirect expenses compensate hospitals for
expenses associated with the treatment of more severely ill patients
and the additional costs relating to teaching residents in such
programs. The Centers for Medicare and Medicaid Services (CMS) issued a
final rule in the Federal Register regarding Sections 5503, 5504, 5505,
and 5506 of the Affordable Care Act of 2010, Public Law 111-148, on
Wednesday, November 24, 2010. This final rule included policy changes
on counting resident time in non-provider settings, counting resident
time for didactic training and the redistribution of resident caps,
which required modification of the data collection forms within the
CHGME Payment Program application. The necessary modifications were
made and received OMB clearance on June 30, 2012.
On September 30, 2013, CMS published revised cost report forms on
their Web site; specifically form CMS 2552-10, Worksheet E-4, requiring
additional modifications of the data collection forms in the CHGME
Payment Program application. The CHGME Payment Program application
forms have been adjusted to accommodate the most recent CMS policy
changes. These changes require OMB approval.
Need and Proposed Use of the Information: Data are collected on the
number of full-time equivalent (FTE) residents in applicant children's
hospitals' training programs to determine the amount of direct and
indirect medical education payments to be distributed to participating
children's hospitals. Indirect medical education payments will also be
derived from a formula that requires the reporting of discharges, beds,
and case mix index information from participating children's hospitals.
Hospitals will also be requested to submit data on the number of
FTE residents trained during the federal fiscal year to participate in
the reconciliation payment process. Auditors will be requested to
submit data on the number of full-time equivalent residents trained by
the hospitals in an FTE resident assessment summary. An assessment of
the hospital data ensures that appropriate CMS regulations and CHGME
program guidelines are followed in determining which residents are
eligible to be claimed for funding. The audit results impact final
payments made by the CHGME Payment Program to all eligible hospitals.
Likely Respondents: Hospitals applying for and receiving CHGME
funds and fiscal intermediaries auditing data submitted by the
hospitals receiving CHGME funds.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information; to search data sources; to complete and
review the collection of information; and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this Information Collection Request are summarized in the table below.
Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
Application Cover Letter 60 1 60 0.33 19.8
(Initial)......................
Application Cover Letter 60 1 60 0.33 19.8
(Reconciliation)...............
HRSA 99 (Initial)............... 60 1 60 0.33 19.8
HRSA 99 (Reconciliation)........ 60 1 60 0.33 19.8
HRSA 99-1 (Initial)............. 60 1 60 26.50 1,590.0
HRSA 99-1 (Reconciliation)...... 60 1 60 6.50 390.0
HRSA 99-1 (Supplemental) (FTE 30 1 30 3.67 110.1
Resident Assessment)...........
HRSA 99-2 (Initial)............. 60 1 60 11.33 679.8
HRSA 99-2 (Reconciliation)...... 60 1 60 3.67 220.2
HRSA 99-4 (Reconciliation)...... 60 1 60 12.50 750.0
HRSA 99-5 (Initial)............. 60 1 60 0.33 19.8
HRSA 99-5 (Reconciliation)...... 60 1 60 0.33 19.8
CFO Form Letter (Initial)....... 60 1 60 0.33 19.8
CFO Form Letter (Reconciliation) 60 1 60 0.33 19.8
FTE Resident Assessment Cover 30 1 30 0.33 9.9
Letter (FTE Resident
Assessment)....................
Conversation Record (FTE 30 1 30 3.67 110.1
Resident Assessment)...........
Exhibit C (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit F (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit N (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit O(1) (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit O(2) (FTE Resident 30 1 30 26.50 795.0
Assessment)....................
Exhibit P (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit P(2) (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit S (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit T (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit T(1) (FTE Resident 30 1 30 3.67 110.1
Assessment)....................
Exhibit 1 (FTE Resident 30 1 30 0.33 9.9
Assessment)....................
Exhibit 2 (Initial, 90 1 90 0.33 29.7
Reconciliation and FTE Resident
Assessment)....................
Exhibit 3 (Initial, 90 1 90 0.33 29.7
Reconciliation and FTE Resident
Assessment)....................
[[Page 22504]]
Exhibit 4 (Initial, 90 1 90 0.33 29.7
Reconciliation and FTE Resident
Assessment)....................
-------------------------------------------------------------------------------
Total....................... 90 .............. 90 .............. 5,962.8
----------------------------------------------------------------------------------------------------------------
Dated: April 14, 2014.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2014-09186 Filed 4-21-14; 8:45 am]
BILLING CODE 4165-15-P
